Koppel Adam
Cerevel Therapeutics Holdings, Inc. · Director, 10% Owner
Koppel Adam is listed in public filings as director, 10 percent owner:. This Koppel Adam insider trading page organizes Form 4 disclosures, reported purchases and sales, transaction dates, share amounts, related issuers, and historical insider activity so readers can review the person's public trading record in one place. Companies and tickers connected to this insider trading profile include Cerevel Therapeutics Holdings, Inc. (CERE), and Foghorn Therapeutics Inc. (FHTX). Investors use Koppel Adam's insider trading disclosures to study buying and selling patterns, position changes, company-specific activity, and the source evidence behind each reported transaction.
Latest Actions
| Company | Holding Value | Last Transaction | Amount | Transaction Price | Current Price |
|---|---|---|---|---|---|
| $065.7M shares | OtherAug 1, 2024 | $3.0B65.7M shares | $45.00 | -- | |
| --80.2k shares | OtherAug 1, 2024 | Disclosure amount unavailable80.2k shares | -- | -- | |
| --10.5k shares | OtherAug 1, 2024 | Disclosure amount unavailable10.5k shares | -- | -- | |
| $471k10.5k shares | OtherAug 1, 2024 | $147.7K3.3k shares | $45.00 | -- |
Insider Trades History
| Company | Holding Value | Last Transaction | Amount | Transaction Price | Current Price |
|---|---|---|---|---|---|
| $88k16k shares | Grant / ExerciseJun 26, 2024 | $88.3K16k shares | $5.52 | -- |